Skip to main content

Peer Review reports

From: Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudy

Original Submission
23 Jun 2009 Submitted Original manuscript
24 Jun 2009 Author responded Author comments - Zhe Zhang
Resubmission - Version 2
24 Jun 2009 Submitted Manuscript version 2
Publishing
24 Aug 2009 Editorially accepted
24 Aug 2009 Article published 10.1186/1741-7015-7-41

You can find further information about peer review here.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us